Sister Study To Examine Risk Factors For Breast Cancer In 50,000 Women
Some Children With Hodgkin’s Disease Can Reduce Or Skip Radiation, Study Finds
Breast Implants Don’t Cause Tissue Disorders, NCI Finds
Unscreened Women At High Risk of Breast Cancer
Efaproxyn Improved Survival Of Patients With Brain Mets
Brachytherapy Better Than Surgery For Prostate Cancer
Ohio Center Helps Women Stop Smoking, Reduce Cervical Cancer Risk
Smoking Cessation Training Follows Doctors Into Practice
Degarelix Active In Phase II Trial In Prostate Cancer
Study Opens For Women At Risk of Ovarian Cancer
Centers Recruting Patients With Mantle Cell Lymphoma
NCI-Approved Clinical Trials
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
